Division of Hematology, Stanford University School of Medicine, 269 Campus Drive, CCSR 3100, Stanford, CA, 94305, USA,
Cell Mol Life Sci. 2014 Sep;71(18):3489-506. doi: 10.1007/s00018-014-1625-0. Epub 2014 Apr 24.
Angiogenesis, the formation of new blood vessels from pre-existing vessels, in the central nervous system (CNS) is seen both as a normal physiological response as well as a pathological step in disease progression. Formation of the blood-brain barrier (BBB) is an essential step in physiological CNS angiogenesis. The BBB is regulated by a neurovascular unit (NVU) consisting of endothelial and perivascular cells as well as vascular astrocytes. The NVU plays a critical role in preventing entry of neurotoxic substances and regulation of blood flow in the CNS. In recent years, research on numerous acquired and hereditary disorders of the CNS has increasingly emphasized the role of angiogenesis in disease pathophysiology. Here, we discuss molecular mechanisms of CNS angiogenesis during embryogenesis as well as various pathological states including brain tumor formation, ischemic stroke, arteriovenous malformations, and neurodegenerative diseases.
血管生成,即从预先存在的血管中形成新的血管,在中枢神经系统(CNS)中既是一种正常的生理反应,也是疾病进展过程中的病理性步骤。血脑屏障(BBB)的形成是生理CNS 血管生成的一个重要步骤。BBB 由内皮细胞和周细胞以及血管星形胶质细胞组成的神经血管单元(NVU)调节。NVU 在防止神经毒性物质进入和调节 CNS 中的血流方面起着关键作用。近年来,对 CNS 中许多获得性和遗传性疾病的研究越来越强调血管生成在疾病病理生理学中的作用。在这里,我们讨论胚胎发生过程中 CNS 血管生成的分子机制,以及包括脑肿瘤形成、缺血性中风、动静脉畸形和神经退行性疾病在内的各种病理状态。